⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ELVN News
Enliven Therapeutics, Inc. Common Stock
Enliven Therapeutics Announces New CEO to Drive Next Phase of Development
prnewswire.com
ELVN
Liver Cancer Drug Market Poised to Reach US$ 17.2 Billion by 2033 Amid Rapid Advances in Targeted Therapies | Astute Analytica
globenewswire.com
BMY
MRK
AZN
ELVN
REGN
GILD
NVS
SNY
Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update
prnewswire.com
ELVN
Enliven Therapeutics Announces Clinical Data in CML Patients with Atypical Fusion Transcripts at ASH 2025 Annual Meeting
prnewswire.com
ELVN
Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2025 Annual Meeting
prnewswire.com
ELVN